In this retrospective observational cohort study, we analyzed pretreatment serum samples and data for a cohort of RA patients and used multiple linear regression analysis to reveal biomarkers that predicted RA patients’ week 16 DAS28-CRP score to tocilizumab or etanercept therapy. Here, CRP is linked to rheumatoid arthritis.